🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-center, stratified and single-blinded Phase 2 trial of neoa...
Status
Completed
Location
IRCCS Ospedale San Raffaele Hospital Vita-Salute San Raffaele University
Start Date
2023-09-06
Trial ID
NCT06059547
Treatments Being Tested
This is an exploratory, signal-finding, randomized, placebo-controlled, bli...
Status
Recruiting
Location
University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center)
Start Date
2025-10-07
Trial ID
NCT07246863
This is a Phase 2b, randomized, blinded clinical trial investigating the ef...
Status
Recruiting
Location
USC Norris Comprehensive Cancer Center
Start Date
2026-03-19
Trial ID
NCT07219459
Treatments Being Tested
A study of how well and safely a new drug called visugromab works in people...
Status
Recruiting
Location
Eastern Connecticut Hematology & Oncology
Start Date
2026-04-16
Trial ID
NCT07112196
Treatments Being Tested
The Phase 1 part (Part A) is a dose escalation study of IV visugromab (CTL-...
Status
Active Not Recruiting
Location
Universitätsklinikum Essen, Westdeutsches Tumorzentrum, Innere Klinik und Poliklinik
Start Date
2020-12-09
Trial ID
NCT04725474
Treatments Being Tested
This is an exploratory, signal finding, randomized, placebo-controlled, bli...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-08-01
Trial ID
NCT07098988